Skip to main content
PYC THERAPEUTICS LIMITED logo

PYC THERAPEUTICS LIMITED — Investor Relations & Filings

Ticker · PYC ISIN · AU000000PYC7 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,297 across all filing types
Latest filing 2026-02-08 Capital/Financing Update
Country AU Australia
Listing ASX PYC

About PYC THERAPEUTICS LIMITED

https://pyctx.com/

PYC Therapeutics Limited is a clinical-stage company focused on developing precision medicines for patients with rare genetic diseases. The company utilizes a proprietary drug delivery platform that combines naturally derived cell-penetrating peptides with antisense oligonucleotides to create RNA-based therapeutics. This platform is designed to overcome the challenges of delivering large therapeutic molecules into target cells, particularly within the eye and central nervous system. PYC's primary pipeline includes VP-001, a candidate for Retinitis Pigmentosa type 11, and PYC-001, targeting Autosomal Dominant Optic Atrophy. Additionally, the company is advancing programs for Polycystic Kidney Disease. By leveraging its delivery technology, PYC aims to address the underlying genetic causes of diseases that currently lack effective treatment options.

Recent filings

Filing Released Lang Actions
Retail Offer Booklet 115 pages 4.4MB
Capital/Financing Update Classification · 95% confidence The document is titled 'Retail Offer Booklet' and relates to a 3 for 5 pro rata accelerated non-renounceable entitlement offer by PYC Therapeutics Limited. It includes detailed information about the retail component of the entitlement offer, instructions for shareholders, legal disclaimers, and international offer restrictions. The document is a comprehensive booklet intended for investors to understand and participate in the capital raising. It is not a financial report, earnings release, or management discussion. It is clearly related to a capital raising activity and the issuance of new shares. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the actual offer booklet, not just an announcement of the offer. Hence, the classification is CAP with high confidence.
2026-02-08 English
Notification to Ineligible Retail Shareholders 4 pages 323.9KB
Capital/Financing Update Classification · 95% confidence The document is a letter dated 9 February 2026 from PYC Therapeutics Limited informing certain shareholders that they are ineligible to participate in a pro-rata accelerated non-renounceable entitlement offer announced earlier. It details the terms of the entitlement offer, eligibility criteria, and regulatory compliance under the Corporations Act and ASX Listing Rules. The document is a notification to shareholders about their ineligibility to participate in a capital raising event and does not contain financial statements or detailed financial analysis. It is not a report but an announcement related to a capital raising activity. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is over 10,000 characters and contains substantive information about the capital raising, not just a brief announcement or a report publication notice.
2026-02-08 English
Despatch of Retail Offer Booklet 2 pages 184.0KB
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 9 February 2026 regarding the despatch of a retail entitlement offer booklet and the commencement of a retail entitlement offer for PYC Therapeutics Limited. It discusses the details of the entitlement offer, including the offer period and instructions for shareholders, but does not contain any financial statements or detailed financial data. The document is relatively short (3173 characters) and serves as a notification about the offer process rather than the offer itself or detailed financial results. This fits the category of a Capital/Financing Update, as it relates to company fundraising activities and capital structure changes through an entitlement offer.
2026-02-08 English
Investor Webinar 2 pages 194.7KB
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 5 February 2026 about an upcoming investor webinar scheduled for 24 February 2026. The content focuses on inviting shareholders and investors to attend the webinar, which will cover updates on a recent capital raise and progress on drug development programs. There are no financial statements, detailed financial data, or comprehensive report content included. The document is relatively short (3111 characters) and serves as a notification of an event rather than a detailed financial or regulatory report. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not a certification or legal proceeding. The primary purpose is to inform investors about a webinar related to capital raising and company updates. This aligns best with a Capital/Financing Update (CAP) filing type, which covers updates on fundraising and financing activities.
2026-02-04 English
Completion of Placement and Institutional Entitlement Offer 4 pages 232.4KB
Capital/Financing Update Classification · 100% confidence The document is an announcement dated 4 February 2026 regarding the completion of a placement and institutional entitlement offer by PYC Therapeutics Limited. It details the capital raising activities, including the amounts raised, underwriting agreements, and the upcoming retail entitlement offer. The content focuses on financing activities, share issuance, and capital structure changes. There are no financial statements or detailed financial performance data presented, nor is this a report or presentation of financial results. The document is not a report publication announcement since it contains substantive information about the capital raising event itself. Therefore, the document fits the category of Capital/Financing Update (CAP).
2026-02-03 English
Trading Halt 2 pages 304.6KB
Capital/Financing Update Classification · 95% confidence The document is a market announcement from PYC Therapeutics Limited regarding a trading halt requested pending the release of an announcement related to a capital raising via entitlement offer and placement. It is a short notice primarily about the trading halt and does not contain any financial data, detailed report, or results. The document is an announcement about a trading halt and upcoming capital raising, not the capital raising update itself or a financial report. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to financing activities and capital structure changes.
2026-02-01 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.